Clinical Trial Update: Two Center Study to Determine Effect of G17DT on Plasma Gastrin Levels in Patients With Colorectal Cancer. [Phase 2]

View source ↗

Summary

Completed Phase 2 trial evaluating the effect of G17DT on plasma gastrin levels in patients with colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• G17DT

Snippet

Sponsor: Cancer Advances Inc. | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED